Loading...

Kenvue Inc.

KVUENYSE
Consumer DefensiveHousehold & Personal Products
$21.73
$0.07(0.35%)

Kenvue Inc. (KVUE) Stock Overview

Explore Kenvue Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
0.07%
0.07%
Profit Growth
$0.55
38.10%
EPS Growth
$0.55
40.00%
Operating Margin
15.76%
26.71%
ROE
10.42%
38.10%
Dividend Yield
0.00%
89.70%

Analyst Recommendations

Strong Buy
0
Buy
3
Hold
2
Sell
0
Strong Sell
0

Price Targets

Low$21.00
Average$25.17
High$29.00

Company Profile

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

CEO

Mr. Thibaut Mongon

Employees

22,000

Headquarters

199 Grandview Road, Skillman, NJ

Founded

2023

Frequently Asked Questions